Slingshot members are tracking this event:
Pfizer (PFE) And Lilly (LLY) Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab at 16-weeks For The Treatment Of Osteoarthritis (OA) Pain
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jul 18, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Tanezumab, Osteoarthritis Pain, Subcutaneous Administration, Phase 3 Top Line Results, Positive Phase 3 Topline Results